AKT1 and diabetic kidney disease: Oleanolic acid (OA), a potential drug for DKD, has been shown to increase autophagy by regulating miR-142-5p/PTEN through inhibition of the PI3K/AKT/mTOR pathway, thereby decreasing interstitial fibrosis (Chen et al., 2019).